GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » American Cryostem Corp (OTCPK:CRYO) » Definitions » Shiller PE Ratio

American Cryostem (American Cryostem) Shiller PE Ratio : (As of Jun. 09, 2024)


View and export this data going back to 2010. Start your Free Trial

What is American Cryostem Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


American Cryostem Shiller PE Ratio Historical Data

The historical data trend for American Cryostem's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

American Cryostem Shiller PE Ratio Chart

American Cryostem Annual Data
Trend Sep12 Sep13 Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

American Cryostem Quarterly Data
Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of American Cryostem's Shiller PE Ratio

For the Biotechnology subindustry, American Cryostem's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


American Cryostem's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, American Cryostem's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where American Cryostem's Shiller PE Ratio falls into.



American Cryostem Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

American Cryostem's E10 for the quarter that ended in Jun. 2022 is calculated as:

For example, American Cryostem's adjusted earnings per share data for the three months ended in Jun. 2022 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Jun. 2022 (Change)*Current CPI (Jun. 2022)
=-0.009/125.0168*125.0168
=-0.009

Current CPI (Jun. 2022) = 125.0168.

American Cryostem Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201209 -0.058 97.633 -0.074
201212 -0.008 96.871 -0.010
201303 -0.011 98.209 -0.014
201306 -0.011 98.518 -0.014
201309 -0.051 98.790 -0.065
201312 -0.009 98.326 -0.011
201403 -0.015 99.695 -0.019
201406 -0.007 100.560 -0.009
201409 -0.032 100.428 -0.040
201412 -0.007 99.070 -0.009
201503 -0.005 99.621 -0.006
201506 -0.005 100.684 -0.006
201509 -0.023 100.392 -0.029
201512 -0.002 99.792 -0.003
201603 -0.004 100.470 -0.005
201606 -0.009 101.688 -0.011
201609 -0.038 101.861 -0.047
201612 -0.003 101.863 -0.004
201703 0.000 102.862 0.000
201706 0.000 103.349 0.000
201709 -0.028 104.136 -0.034
201712 -0.010 104.011 -0.012
201803 -0.005 105.290 -0.006
201806 -0.010 106.317 -0.012
201809 0.000 106.507 0.000
201812 -0.006 105.998 -0.007
201903 -0.007 107.251 -0.008
201906 -0.007 108.070 -0.008
201909 0.000 108.329 0.000
201912 -0.005 108.420 -0.006
202003 -0.003 108.902 -0.003
202006 -0.004 108.767 -0.005
202009 -0.007 109.815 -0.008
202012 -0.001 109.897 -0.001
202103 -0.005 111.754 -0.006
202106 -0.008 114.631 -0.009
202109 -0.036 115.734 -0.039
202112 -0.007 117.630 -0.007
202203 -0.022 121.301 -0.023
202206 -0.009 125.017 -0.009

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


American Cryostem  (OTCPK:CRYO) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


American Cryostem Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of American Cryostem's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


American Cryostem (American Cryostem) Business Description

Traded in Other Exchanges
N/A
Address
1 Meridian Road, Suite 5, Eatontown, NJ, USA, 07724
American Cryostem Corp is a biotechnology company which standardizes adipose tissue-derived technologies (Adult Stem Cells) for the fields of Regenerative and Personalized Medicine. The company acts as an innovator of adipose tissue and stem cell platform technologies. It provides the clinical grade, adipose tissue and adult stem cell collection, processing, and cryo-preservation technology, providing first-in-class cellular therapy products and services for patients, physicians and researchers based on the transformative science of Regenerative and Personalized Medicine.
Executives
John S Arnone director, officer: Chairman 111 GREAT NECK RD, GREAT NECK NY 11021
Anthony Francis Dudzinski director, officer: COO 188 EAST BERGEN PLACE, SUITE 204, RED BANK NJ 07701
Acs Global, Inc. 10 percent owner 188 E. BERGEN PLACE, SUITE 204, RED BANK NJ 07701
Christopher Joseph Neill 10 percent owner 188 EAST BERGEN PLACE, SUITE 204, RED BANK NJ 07701
Hector Medina director, 10 percent owner, officer: President and Director 1206 STAGECOACH TRAIL LOOP, CHULA VISTA CA 91915